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Blood basophils are reduced in chronic urticaria and
respond less well to immunologic stimuli. Active
recruitment of basophils from peripheral blood into
lesional skin may be important in wheal patho-
genesis. Key word: autoantibodies. Journal of Investigative
Dermatology Symposium Proceedings 6:139±140, 2001
N
ot much is known about the physiology and fate of
basophils in urticaria, but it is possible that they
have a direct role because ``releasability'' to anti-IgE
has been shown to be reduced and peripheral blood
basopenia appears to relate to serum histamine
releasing activity in chronic disease. Preliminary ®ndings indicate
that numbers are negatively correlated with urticarial activity,
supporting the hypothesis that they migrate from blood into skin
during wheal formation and contribute to persistence of the wheal.
Basophils comprise about 1% of the circulating granulocytes in
humans. In healthy subjects this represents about 40 basophils per ml
of whole blood, which equates to around 200 million in the
circulation at any time. They are characterized by granules that
stain with basic dyes. Despite many similarities with tissue mast cells
they show developmental, phenotypic, and functional differences.
Basophils and mast cells almost certainly arise from a common bone
marrow stem cell. Whereas the conditions required for maturation
of the basophil are unclear, the phenotype of tissue mast cells is
controlled by the local cytokine environment. Mucosal mast cells
containing tryptase (MCT cells) mature under the in¯uence of
interleukins 3 and 4, but connective tissue mast cells containing
tryptase and chymase (MCTC) require the presence of ®broblasts.
The survival of blood basophils is unknown but is probably less
than mast cells. The fate of basophils that have degranulated in
response to a stimulus is not certain, but recovery of the granules
within 6 h appears possible (Dvorak et al, 1996) and basophils are
capable of division (Stock and Hoffman, 2000). Both basophils and
mast cells express the high-af®nity IgE receptor (FceRI) and release
preformed histamine, which is the major mediator of urticaria.
Secondary mediators, newly synthesized on degranulation, differ in
their proportions: leukotriene C4 is formed by basophils whereas
mast cells predominantly form prostaglandin D2. Stimulated mast
cells produce a wide range of cytokines, including IL-1, -3±8, -10,
-13, GM-CSF, IFN-g, and TNF-a, but cytokine expression by
activated basophils is restricted to IL-4 and -13.
There is relatively little literature on basophils in health and
disease. This is partly because they are present in low numbers in
peripheral blood and are dif®cult to quantify accurately with
automated differentials. Basophils and mast cells cannot be distin-
guished easily in tissue with conventional stains. Most of the
current literature relates to the use of basophils in the diagnosis of
allergic disease and histamine releasing activity of serum in urticaria,
using assays of functional activity.
Basophil releasability (as de®ned by maximum histamine release
with a de®ned stimulus) was shown to be reduced with anti-IgE in
chronic urticaria basophils by Greaves et al (1974) and Lichtenstein
(Kern and Lichtenstein 1976) in the 1970s, although the explan-
ation for this was not clear at the time. The much later ®nding of
functional anti-IgE (Grattan et al 1991) and anti-FceRI (Hide et al
1993) autoantibodies in the serum of some chronic ``idiopathic''
urticaria patients implies that circulating basophils in these patients
may be in a state of desensitization from further stimulation through
the FceRI. Zuberbier et al (1996) con®rmed the reduction of
basophil releasability in chronic urticaria with anti-IgE as the
stimulus, but found this did not apply to skin mast cells. Sabroe et al
(1998) demonstrated reduced basophil releasability in chronic
urticaria with anti-IgE and a murine monoclonal antibody against
the FceRI but not FMLP. The greatest reduction was seen with
autoantibody-positive patients.
Blood basophils may be increased in myxedema and diabetes
mellitus and reduced in hyperthyroidism, pregnancy, ovulation,
after administration of corticosteroids, and in chronic urticaria
(Sabroe et al, 1998; Rorsman 1961; Rorsman et al, 1962; Grattan
et al 1997). Urticaria appears to be the only clinical disorder where
basophil enumeration may be of immediate clinical relevance.
Rorsman (1961) found that peripheral blood basophils were
reduced in idiopathic urticaria (mean 5 per ml) by comparison
with healthy subjects (45 per ml) using a metachromatic granule
stain on peripheral blood, but were not reduced in physical
urticarias (Rorsman et al 1962). He also noted that the basopenia of
urticaria was only sustained during periods of disease activity. His
results were later con®rmed and extended by Grattan et al (1997)
who found that blood basophil numbers in chronic ``idiopathic''
urticaria related to the histamine releasing activity of serum from
the same patients. Those with serum activity that released histamine
from basophils of healthy donors had few or absent circulating
basophils. This was true whether the counts were done with a
manual counting chamber method using toluidine blue staining of
basophil granules or ¯ow cytometry employing a dual stain for
membrane markers, indicating that the cells had disappeared from
the circulation rather than being rendered invisible to granule stains
by activation. Sabroe et al (1998) looked at chronic urticaria
patients with or without evidence of functional autoantibodies
(de®ned by histamine releasing activity) and found that the mean
numbers were reduced in nonantibody patients (although less so
than anitbody-positive patients) when compared with controls.
There were comparable reductions in total cellular blood histamine
in each group.
The fate of the missing blood basophils in chronic urticaria
remains unclear. It is possible that they are actively recruited into
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wheals by expression of endothelial adhesion molecules, including
VCAM-1, induced by degranulation of lesional skin mast cells. This
might explain the prolongation of ``idiopathic'' urticaria wheals
well beyond the expected time course of histamine-induced wheals
in healthy subjects (Cook and Shuster, 1980). A 14-fold increase of
basophil numbers was found in biopsies of the late cutaneous
response of immediate hypersensitivity reactions to antigen chal-
lenge, which correlated with a late increase in tissue histamine
(Charlesworth et al, 1989). Binding of FceRI on cutaneous mast
cells by autoantibodies rather than allergen could have similar
consequences in chronic urticaria. Histologic studies of urticarial
wheals using monoclonal antibody stains for basophil membrane
markers should address this. Recent work has been focused on
measuring blood basophil numbers in relation to urticarial activity
over the course of a day and assessing the effects of treatment with
antihistamines and oral corticosteroids. It might be expected that a
reduction in urticarial wheals would lead to an increase in blood
basophils if active recruitment into lesional skin is inhibited.
Preliminary analysis of the study results shows that there is little
variation in blood basophil numbers over the day in healthy
controls and chronic urticaria patients off treatment, although a
marked basopenia was present in the urticaria patients. A sharp
reduction of basophil numbers was seen in healthy controls after
taking oral corticosteroids from around 45 per ml to10 per ml of
whole blood. Conversely, basophil numbers increased from around
5 per ml to 10 per ml in the chronic urticaria patients. These results
suggest there is a two-way traf®c of circulating basophils between
blood and tissues in health and disease. As well as inhibiting IL-4
secretion (Schroeder et al, 1997) and IgE-dependent histamine
release (Schleimer et al, 1982) from basophils, it seems that
corticosteroids may in¯uence endothelial mechanisms (such as
constitutive adhesion molecule expression) that regulate the return
of migrating basophils to the circulation when not actively engaged
in tissue in¯ammation. A signi®cant negative linear correlation
between blood basophil numbers and urticarial activity scores lends
some support to the hypothesis that they may contribute directly to
the pathogenesis of urticarial wheals in ``idiopathic'' urticaria.
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